☆ 4.6 Article

Expanding and improving nanobody repertoires using a yeast display method: Targeting SARS-CoV-2

JOURNAL OF BIOLOGICAL CHEMISTRY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Multidisciplinary Sciences

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Elisabetta Cameroni et al.

Summary: The Omicron variant of SARS-CoV-2 has raised concerns due to its 37 amino acid substitutions in the spike protein, particularly in the receptor-binding domain (RBD), leading to increased binding affinity with human ACE2. Neutralizing activity against Omicron was greatly reduced in convalescent and vaccinated individuals compared to the ancestral virus, but this decrease was less significant after a third vaccine dose. Broadly neutralizing monoclonal antibodies recognizing conserved RBD epitopes may be crucial in combating the Omicron variant and future zoonotic transmissions.

NATURE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution

Tyler N. Starr et al.

Summary: This study investigates the impact of mutations in the spike receptor-binding domain (RBD) of SARS-CoV-2 on its affinity for the ACE2 receptor and antibody recognition, as well as their implications for future evolution and interaction. The findings reveal that certain mutations cause shifts in the effects of mutations at other sites, shaping the evolutionary path of the virus.

SCIENCE (2022)

添加到收藏夹

Article Immunology

An alpaca single-domain antibody (VHH) phage display library constructed by CDR shuffling provided high-affinity VHHs against desired protein antigens

Narutoshi Tsukahara et al.

Summary: The study constructed a camelid VHH phage display library using CDR shuffling technique, which can provide functional VHH fragments against different antigens with affinities similar to immunized antigens.

INTERNATIONAL IMMUNOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

A guide to: generation and design of nanobodies

Serge Muyldermans

Summary: Nanobodies, a trademark of Ablynx, are single antigen-binding domains of heavy chain-only antibodies in Camelidae produced recombinantly for research and medical applications. Various methods are used for their generation, producing cost-effective Nbs with high affinity for their target antigens. Additionally, engineering technologies have been explored to broaden the application range of Nbs for potential advantages over other affinity reagents.

FEBS JOURNAL (2021)

添加到收藏夹

Article Microbiology

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

Allison J. Greaney et al.

Summary: Antibodies targeting the SARS-CoV-2 spike receptor-binding domain (RBD) are key in neutralizing antibody responses, and a deep mutational scanning method was used to assess the impact of all amino-acid mutations in the RBD on antibody binding with 10 human monoclonal antibodies. The study identified the clustered escape mutations in different surfaces of the RBD that correspond to structurally defined antibody epitopes, showing that even antibodies targeting the same surface can have distinct escape mutations.

CELL HOST & MICROBE (2021)

添加到收藏夹

News Item Multidisciplinary Sciences

The lightning-fast quest for COVID vaccines - and what it means for other diseases

Philip Ball

Summary: The rapid approach used to address SARS-CoV-2 has the potential to revolutionize the future of vaccine science.

NATURE (2021)

添加到收藏夹

Editorial Material Immunology

Transition to endemicity: Understanding COVID-19

Rustom Antia et al.

Summary: The article discusses the basic concepts underlying the transition from an epidemic to an endemic state, as well as the implications of this transition for COVID-19.

IMMUNITY (2021)

添加到收藏夹

Review Virology

Structural Biology of Nanobodies against the Spike Protein of SARS-CoV-2

Qilong Tang et al.

Summary: Nanobodies, derived from heavy-chain-only subclass of Camelid immunogloblins, are small-sized molecules with high affinity and stability, making them unique targeting reagents in biomedical sciences. With the rapid spread of SARS-CoV-2, nanobodies directed against the viral Spike protein have shown promising results in neutralizing the virus, with some agents already undergoing clinical trials. Researchers are studying the structural features guiding nanobody recognition to develop effective treatments against the pandemic.

VIRUSES-BASEL (2021)

添加到收藏夹

Article Biology

Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape

Fred D. Mast et al.

Summary: Researchers generated a large nanobody repertoire to target distinct and highly conserved epitopes on the SARS-CoV-2 spike protein, identifying new nanobody binding sites that can inhibit viral infection and combat viral variants effectively.

ELIFE (2021)

添加到收藏夹

Article Microbiology

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection

Hejun Liu et al.

Summary: This study presents a cross-neutralizing antibody, CV38-142, which can accommodate antigenic variation in SARS-related viruses, providing valuable information for addressing current and future antigenic drift in SARS-CoV-2 and protecting against zoonotic SARS-related coronaviruses.

CELL HOST & MICROBE (2021)

添加到收藏夹

Review Immunology

Immune response against SARS-CoV-2 variants: the role of neutralization assays

Alicja Maria Chmielewska et al.

Summary: This article discusses the background of the COVID-19 pandemic, the development of vaccines, and concerns about virus variants. It also evaluates common experimental methods used to test neutralizing antibody responses against SARS-CoV-2 variants. In addition, recent studies on the immune responses elicited by available vaccines against major SARS-CoV-2 variants are briefly reviewed.

NPJ VACCINES (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice

Phillip Pymm et al.

Summary: Neutralizing antibodies, particularly nanobodies, play a crucial role in immunity against SARS-CoV-2 and in the development of therapeutics for COVID-19. Researchers have identified high-affinity nanobodies that effectively disrupt the interaction between the virus and the human host cell receptor ACE2, offering promising prophylactic potential against SARS-CoV-2. Studies have shown that nanobody-Fc fusions can block viral engagement with host cells and significantly reduce viral loads in infected mice, suggesting their use as preventive agents against COVID-19.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

添加到收藏夹

Editorial Material Multidisciplinary Sciences

The story behind COVID-19 vaccines

Anthony S. Fauci

SCIENCE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Delphine Planas et al.

Summary: The SARS-CoV-2 B.1.617 Delta variant, first identified in India in 2020, has become dominant in some regions and is spreading to many countries. This variant shows resistance to certain monoclonal antibodies and antibodies in convalescent sera, as well as reduced neutralization by some COVID-19 vaccines. Administration of two doses of the vaccine is needed for a neutralizing response against the Delta variant.

NATURE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants

Jianliang Xu et al.

Summary: The study found that camelid nanobodies can effectively circumvent vaccine escape caused by mutations in the novel coronavirus. These nanobodies are able to neutralize SARS-CoV-2 variants through two mechanisms, demonstrating promising potential in preventing COVID-19 mortality when vaccines are compromised.

NATURE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies

Allison J. Greaney et al.

Summary: The study found that although the human immune system can produce antibodies that target diverse RBD epitopes, in practice, the polyclonal response to infection tends to be skewed towards a single class of antibodies targeting an epitope that is already undergoing rapid evolution.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis

Jennifer M. Zupancic et al.

Summary: There is a strong interest in developing effective methods for generating neutralizing antibodies and nanobodies against SARS-CoV-2. This study presents a simple directed evolution method for producing nanobodies with high affinities and neutralization activities, which can effectively neutralize both SARS-CoV-2 pseudovirus and live virus.

CELL CHEMICAL BIOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses

Sham Nambulli et al.

Summary: The study demonstrates the high efficacy of PiN-21 in preventing and treating SARS-CoV-2 infection in Syrian hamsters modeling moderate to severe COVID-19. Intranasal delivery of PiN-21 effectively protects infected animals from weight loss and reduces viral burdens in both lower and upper airways.

SCIENCE ADVANCES (2021)

添加到收藏夹

Review Oncology

The Therapeutic Potential of Nanobodies

Ivana Jovcevska et al.

BIODRUGS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

添加到收藏夹

Article Microbiology

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Michael Letko et al.

NATURE MICROBIOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls et al.

CELL (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Site-specific glycan analysis of the SARS-CoV-2 spike

Yasunori Watanabe et al.

SCIENCE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

Jiangdong Huo et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Structure-based design of prefusion-stabilized SARS-CoV-2 spikes

Ching-Lin Hsieh et al.

SCIENCE (2020)

添加到收藏夹

Editorial Material Multidisciplinary Sciences

VIEWPOINT: COVID-19 Will SARS-CoV-2 become endemic?

Jeffrey Shaman et al.

SCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike

Michael Schoof et al.

SCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2

Yufei Xiang et al.

SCIENCE (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Benchmarking biopharmaceutical process development and manufacturing cost contributions to R&D

Suzanne S. Farid et al.

MABS (2020)

添加到收藏夹

Article Immunology

Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity

Jianbo Dong et al.

EMERGING MICROBES & INFECTIONS (2020)

添加到收藏夹

Review Genetics & Heredity

The Camel Adaptive Immune Receptors Repertoire as a Singular Example of Structural and Functional Genomics

Salvatrice Ciccarese et al.

FRONTIERS IN GENETICS (2019)

添加到收藏夹

Article Multidisciplinary Sciences

An improved yeast surface display platform for the screening of nanobody immune libraries

Tomasz Uchanski et al.

SCIENTIFIC REPORTS (2019)

添加到收藏夹

Article Virology

Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape

Lingshu Wang et al.

JOURNAL OF VIROLOGY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Yeast surface display platform for rapid discovery of conformationally selective nanobodies

Conor McMahon et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Comparative analysis of nanobody sequence and structure data

Laura S. Mitchell et al.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Yeast surface display platform for rapid discovery of conformationally selective nanobodies

Conor McMahon et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structural Basis of Epitope Recognition by Heavy-Chain Camelid Antibodies

Uros Zavrtanik et al.

JOURNAL OF MOLECULAR BIOLOGY (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Integrative structure and functional anatomy of a nuclear pore complex

Seung Joong Kim et al.

NATURE (2018)

添加到收藏夹

Review Pharmacology & Pharmacy

Nanobodies®† as inhaled biotherapeutics for lung diseases

Gino Van Heeke et al.

PHARMACOLOGY & THERAPEUTICS (2017)

添加到收藏夹

Review Immunology

Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics

Peter Bannas et al.

FRONTIERS IN IMMUNOLOGY (2017)

添加到收藏夹

Article Biochemical Research Methods

Optimizing selection of large animals for antibody production by screening immune response to standard vaccines

Mary K. Thompson et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2016)

添加到收藏夹

Review Pharmacology & Pharmacy

Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies

Ema Romao et al.

CURRENT PHARMACEUTICAL DESIGN (2016)

添加到收藏夹

Article Biochemical Research Methods

Engineered high-affinity nanobodies recognizing staphylococcal Protein A and suitable for native isolation of protein complexes

Peter C. Fridy et al.

ANALYTICAL BIOCHEMISTRY (2015)

添加到收藏夹

Review Pathology

Emerging technologies in point-of-care molecular diagnostics for resource-limited settings

Rosanna W. Peeling et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2014)

添加到收藏夹

Article Biochemical Research Methods

A robust pipeline for rapid production of versatile nanobody repertoires

Peter C. Fridy et al.

NATURE METHODS (2014)

添加到收藏夹

Review Biochemistry & Molecular Biology

Nanobodies: Natural Single-Domain Antibodies

Serge Muyldermans

ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

An improved yeast transformation method for the generation of very large human antibody libraries

Lorenzo Benatuil et al.

PROTEIN ENGINEERING DESIGN & SELECTION (2010)

添加到收藏夹

Article Cell Biology

Simple kinetic relationships and nonspecific competition govern nuclear import rates in vivo

Benjamin L. Timney et al.

JOURNAL OF CELL BIOLOGY (2006)

添加到收藏夹

Article Agriculture, Multidisciplinary

Selection, characterization, and CDR shuffling of naive llama single-domain antibodies selected against auxin and their cross-reactivity with auxinic herbicides from four chemical families

Claudia Sheedy et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2006)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Nanobodies as novel agents for cancer therapy

H Revets et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.